Valproic Acid in Combination With FEC100 for Primary Therapy in Patients With Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: VPA FEC100
Sponsor: University of California, San Francisco
Collaborators: H. Lee Moffitt Cancer Center and Research Institute